In vitro evaluation of Atenolol tablets produced in Iran with the Atenolol tablets imported from abroad and comparison between them


A. Ashnagar1*, N. Gharib Naseri2, E. Salimi1 and V. Nouruzi1
1School of Pharmacy, Ahwaz Jundi Shapour University of Medical Sciences, Ahwaz (Iran) 2Ahwaz Faculty of Petroleum Engineering, Petroleum University of Technology, Ahwaz (Iran)

Download this article as:  PDF

ABSTRACT:

In vitro evaluation on three types of atenolol tablets produced by three Iranian Pharmaceutical companies (Exir, Darou Pakhsh and Tolid Darou) and three types of atenolol tablest produced by foreign companies (Tenormin? of England, Apo-Atenolol of Canada and Hipres? of India) were carried out. Results obtained in this research have shown that tablets produced in Iran by Exir and Darou Pakhsh Pharmaceutical companies have the minimum standard limits which are acceptable by the internationally well known Pharmacopoeia such as USP, but Atenolol tablets produced by Tolid Darou company, at least in the case of releasing of active ingredient in the desired time, lacks the standard limits. The three imported types of tablets have the internationally acceptable standard limits.

KEYWORDS:

Atenolol, Tenormin?; 4 -[2'-hydroxy-3'-[(1- methylethyl) amino] propoxy]- benzeneacetamide; beta-

Visited 247 times, 1 visit(s) today

Share

FOLLOW US ON:

facebook Twitter Mendeley LinkedIn


SEARCH WEBSITE


MEMBER OF

Logo-image


JOURNAL ARCHIVED IN

Logo-image


Visited 247 times, 1 visit(s) today